Nursing Interventions for Alzheimer's Patients During PET/CT Imaging

NCT ID: NCT06784830

Last Updated: 2025-02-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-15

Study Completion Date

2025-02-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The impact of nursing Interventions during PET/CT imaging in Alzheimer's patients on image quality and patient satisfaction will be assessed in 200 patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will analyze clinical data from 200 Alzheimer's disease (AD) patients who underwent PET imaging and were admitted to Sichuan Provincial People's Hospital over a period of six months. The control group will receive routine nursing intervention, while the observation group will receive a refined specialized nursing intervention. We will meticulously compare various performance aspects in both groups to assess the impact of refined specialized nursing intervention on patients' image quality and patient satisfaction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Refinement of specialized nursing intervention

This specialized nursing emphasizes individualized care plans customized to each patient's unique condition, targeting improvements in both the treatment experience and overall results.

Group Type EXPERIMENTAL

Effects on Image Quality and Patient Satisfaction

Intervention Type OTHER

Effect of nursing intervention on image quality and patient satisfaction during PET/CT imaging in Alzheimer's patients

Anxiety degree of patients after nursing

Intervention Type OTHER

Self Rating Anxiety will be used Scale (SAS) to assess the degree of anxiety after care

Routine nursing intervention

The nurse gave pre-examination education to the control group. All the subjects rested in the waiting room and waited for examination. During the examination, the examination was completed according to the general nursing measures corresponding to different tracers.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Effects on Image Quality and Patient Satisfaction

Effect of nursing intervention on image quality and patient satisfaction during PET/CT imaging in Alzheimer's patients

Intervention Type OTHER

Anxiety degree of patients after nursing

Self Rating Anxiety will be used Scale (SAS) to assess the degree of anxiety after care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Meet the criteria for diagnosing dementia as described in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-R), Use the diagnostic criteria for AD from the National Institute of Neurology, Speech and Communication Disorders and Stroke - Alzheimer's Disease and Related Disorders (NINCDS-ADRDA) or the National Institute on Aging and Alzheimer's Disease Association (NIA-AA).

Exclusion Criteria

* Patients with a history of stroke and focal neurological signs, and imaging findings consistent with small cerebral vascular disease (Fazekas score ≥2);
* The presence of other neurological disorders that can cause brain dysfunction (e.g., depression, brain tumors, Parkinson's disease, metabolic encephalopathy, encephalitis, multiple sclerosis, epilepsy, brain trauma, Normal facial pressure hydrocephalus);
* The presence of other systemic diseases that can cause cognitive impairment (such as liver insufficiency, renal insufficiency, thyroid dysfunction, severe anemia, folic acid or vitamin B12 deficiency, syphilis, HIV infection, alcohol and drug abuse, etc.);
* There is mental and neurological retardation.
* There are other diseases that are known to cause cognitive impairment.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sichuan Provincial People's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hao Wang

Associate senior physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hao Wang, Doctor

Role: STUDY_DIRECTOR

Sichuan Provincial People's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Departments of Nuclear Medicine, Sichuan Provincial People's Hospital

Chengdu, Sichuan, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hao Wang, Doctor

Role: CONTACT

+8618313820216

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hao Wang, Doctor

Role: primary

+86-18313820216

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SichuanPPH-HL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.